NCT01300637 Effects of Adjunctive Metformin on Metabolic Profiles in Clozapine-treated Schizophrenic Patients Status UNKNOWN Phase NA
NCT01296412 Comparison of Two Treatment Regimens (Sitagliptin Versus Liraglutide) on Participants Who Failed to Achieve Good Glucose Control on Metformin Alone (MK-0431-403) Status COMPLETED Phase PHASE3
NCT01289119 Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01286233 Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32 Status UNKNOWN Phase N/A
NCT01280409 Metformin Postpartum for GDM RCT for Reduced Weight Retention Status COMPLETED Phase PHASE4
NCT01279512 Metformin Versus Acarbose Treatment in Infertile Overweight Women With Polycystic Ovary Syndrome (PCOS) Status COMPLETED Phase PHASE4
NCT01278160 Comparison of Biphasic Insulin Aspart 30 Twice Daily With Two Different Initial Dosage Split Regimens in Subjects With Type 2 Diabetes: An Extension to Trial BIASP-3756 Status COMPLETED Phase PHASE4
NCT01274130 Investigatory Study of Metformin's Pharmacokinetics, Pharmacodynamics and Drug Drug Interactions Classifying the Group by MATE1 Genotype in Healthy Volunteers Status COMPLETED Phase NA
NCT01243385 Metformin Hydrochloride as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Prostate Cancer Status COMPLETED Phase PHASE2
NCT01240759 Safety and Efficacy of S-707106 in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control With Metformin Therapy Status COMPLETED Phase PHASE2
NCT01237522 A Pharmacokinetic Evaluation of Metformin in Relation to the Polymorphism A270S in Healthy Caucasian Volunteers Status COMPLETED Phase PHASE4
NCT01233206 Metformin in High Responder Polycystic Ovary Syndrome (PCOS) Patients Undergoing IVF Cycles Status COMPLETED Phase PHASE4
NCT01231074 Reducing Antipsychotic-Induced Weight Gain in Children With Metformin Status COMPLETED Phase PHASE1
NCT01228240 The Efficacy of Metformin Produced by Pars Mino Co in Comparison With Canadian Apotex Co. Status COMPLETED Phase PHASE4